Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2010
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754720 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C
07/13/2010US7754701 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries
07/13/2010US7754228 Cytotoxic T-cell epitopes from Chlamydia
07/13/2010US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient
07/13/2010CA2557536C Amino alcohol compound
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2433096C Methods for the treatment of ibs
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases
07/13/2010CA2356533C Inhibitors of the bitter taste response
07/13/2010CA2347713C Contulakin-g, analogs thereof and uses therefor
07/13/2010CA2345932C Peptide-based carrier devices for stellate cells
07/13/2010CA2297345C Novel antigenic class of avian reoviruses
07/08/2010WO2010078103A1 Modulators of cystic fibrosis transmembrane conductance regulator
07/08/2010WO2010077795A2 Compositions and methods for improved oral health
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010076323A1 Use of ammonium chloride in therapy
07/08/2010WO2010075891A1 Fibcd1 for the prevention and treatment of diseases
07/08/2010WO2010075824A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
07/08/2010WO2010075665A1 A formulation of silibinin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010075663A1 A formulation of silymarin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010049144A3 Ligands for modulation of orphan receptor-gamma (nr1f3 ) activity
07/08/2010WO2010036876A3 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173997 2,4,6-trisubstituted phenols having anesthetic properties
07/08/2010US20100173994 Synthesis of triethylenetetramines
07/08/2010US20100173986 Sesquiterpenes and derivatives thereof for use as feed additives
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173944 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
07/08/2010US20100173942 Phosphodiesterase 4 inhibitors
07/08/2010US20100173925 Oxyindole derivatives
07/08/2010US20100173889 Substituted Pyrimidine and Triazine Compounds
07/08/2010US20100173881 Compositions for the treatment of inflammatory disorders
07/08/2010US20100173876 Oil-based nsaid compositions and methods for making and using same
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010US20100173834 Cyclic peptide melanocortin receptor ligands
07/08/2010US20100173413 Pyridine compounds
07/08/2010US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/08/2010US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound
07/08/2010US20100172973 Pharmaceutical Composition
07/08/2010US20100172959 Reservoir system with closed membrane
07/08/2010US20100172914 Methods and materials related to trail isoforms
07/08/2010US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/08/2010US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins
07/08/2010US20100172905 Antagonists of hmg1 for treating inflammatory conditions
07/08/2010US20100172904 Mcp1 fusions
07/08/2010US20100172902 Method for treating a vcam-1 mediated disease
07/08/2010US20100172901 Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment
07/08/2010US20100172876 Protein free formula
07/08/2010US20100172870 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
07/08/2010US20100172861 Anionic Polymers as Toxin Binders and Antibacterial Agents
07/08/2010DE102009005865A1 Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Dosing and composition for the treatment of inflammatory diseases of the mouth and throat
07/08/2010CA2748493A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
07/08/2010CA2747231A1 Compositions and methods for improved oral health
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2740521A1 Use of ammonium chloride in therapy
07/07/2010EP2204368A1 4-sulfonylpiperidine derivatives
07/07/2010EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
07/07/2010EP2204181A2 Protease inhibitors
07/07/2010EP2204178A1 Laxative agent
07/07/2010EP2204176A2 Nutritional Composition
07/07/2010EP2204175A1 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
07/07/2010EP2203444A1 Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
07/07/2010EP2203177A1 Methods and kits for the treatment of diverticular conditions
07/07/2010EP2203168A2 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection
07/07/2010EP2203152A1 Mouthwash and method of using same for the treatment of mucositis or stomatitis
07/07/2010EP2203068A1 Methods of treating gastrointestinal disorders independent of the intake of food
07/07/2010EP2203055A1 1-methyl nicotinamide and derivatives for treatment of gastric injury
07/07/2010EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes
07/07/2010EP1286669B1 Compositions for prevention of ulcers in horses
07/07/2010CN1778816B Human cell surface membrane molecule and use thereof
07/07/2010CN101772513A Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
07/07/2010CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
07/07/2010CN101768578A Eosinophilic lactase BGALA, gene and application thereof
07/07/2010CN101768559A Lactobacillus, paracasei subsp. paracasei strain, bacteriostatic composition and applications thereof
07/07/2010CN101768215A House lizard glycopeptide, method for preparing same and medicinal application thereof
07/07/2010CN101768152A Piperidine derivatives useful as CCR5 antagonists
07/07/2010CN101768097A Method for preparing selenic acid arginine and application of selenic acid arginine
07/07/2010CN101768095A Preparation method of racecadotril
07/07/2010CN101768080A Medicinal compound and medicinal use thereof
07/07/2010CN101768079A Compound and medicinal application thereof
07/07/2010CN101766812A Liquid drug combination containing exenatide or analogues thereof
07/07/2010CN101766809A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
07/07/2010CN101766807A Injection packaging preparation of thymosin pha1 microspheres
07/07/2010CN101766803A Chinese medicine composite for treating epigastric pain and preparation method thereof
07/07/2010CN101766802A Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof
07/07/2010CN101766799A Ginseng-monkshood centipede health wine
07/07/2010CN101766798A Medicament for treating chronic superficial gastritis
07/07/2010CN101766795A Tablet for treating chronic colitis
07/07/2010CN101766790A Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof
07/07/2010CN101766789A Chinese medicine composite for treating appendicitis and preparation method thereof
07/07/2010CN101766786A Method for extraction of Chinese medicine composite for liver disease
07/07/2010CN101766785A Chinese herbal composite for treatment of liver disease
07/07/2010CN101766783A Traditional Chinese medicine combination for treating cholecystitis and capsule preparation method thereof
07/07/2010CN101766782A Chinese medicine composite for treating chronic gastritis and preparation method thereof
07/07/2010CN101766781A Ironing agent for children deficiency-cold in spleen and stomach, preparation method and application thereof
07/07/2010CN101766780A Sandalwood-containing traditional Chinese medicine for treating gastrointestinal diseases and preparation method thereof
1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 1258